Vindon Healthcare Plc Cancellation of Admission to Trading on AIM (2441O)
September 18 2013 - 1:00AM
UK Regulatory
TIDMVDN
RNS Number : 2441O
Vindon Healthcare Plc
18 September 2013
18 September 2013
Vindon Healthcare plc
("Vindon" or the "Company")
Cancellation of Admission to Trading on AIM
The Company announces that it has applied to the London Stock
Exchange for the cancellation of trading of Vindon's shares on AIM.
In accordance with AIM Rule 41, cancellation will take place no
earlier than 20 business days from today's date and it is currently
anticipated that cancellation will take effect from 7.00 a.m. on 16
October 2013.
This follows the announcement earlier today by Source BioScience
plc ("Source BioScience") that its recommended cash offer ("Offer")
to acquire the whole of the issued and to be issued share capital
of Vindon had been declared wholly unconditional and that it
intended to procure that Vindon applied for the cancellation of
trading of the Company's shares on AIM. In the same announcement,
Source BioScience stated that it intended, pursuant to its rights
under sections 974 to 991 (inclusive) of the Companies Act 2006, to
acquire compulsorily all of the Vindon shares in respect of which
valid acceptances of the Offer had not been received.
Vindon shareholders should note that cancellation is likely to
reduce significantly the liquidity and marketability of Vindon
shares. Once cancellation has taken effect, Vindon shareholders
will no longer be able to effect transactions in Vindon shares on
market at the market price. Following cancellation, therefore,
Vindon shareholders will have to effect any further transactions in
Vindon shares off market at a price to be agreed between the
relevant parties. Shareholders are still able to buy and sell
Vindon shares prior to the cancellation.
Enquiries
Vindon Healthcare plc
Liam Ferguson, Chairman
Tel: +44 (0) 1706 716710
Email: info@vindonhealthcare.com
www.vindonhealthcare.com
For investor and media enquiries:
WH Ireland Limited
Dan Bate (Nominated Adviser)
Jessica Metcalf (Corporate Broking)
Tel: +44(0)161 832 2174
Zeus Capital Limited (Financial Advisor)
Andrew Jones / Nick Cowles
Tel: +44 (0)161 831 1512
www.zeuscapital.co.uk
The Communications Portfolio
Ariane Comstive
Tel: +44 (0) 20 7536 2028/29
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCSFMFMWFDSEEU
Vindon Healthcare (LSE:VDN)
Historical Stock Chart
From May 2024 to Jun 2024
Vindon Healthcare (LSE:VDN)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about Vindon H. (London Stock Exchange): 0 recent articles
More Vindon Healthcare News Articles